SCHEMBL13219224

SCHEMBL13219224

COc1cnc2c(c1)c(CCC(=O)O)nn2S(=O)(=O)c1ccc(CNc2ccc3cccnc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 3/20 0.43
▸ P2RY14 Q15391 2/20 0.41
▸ FFAR1 O14842 2/20 0.39
▸ EGLN2 Q96KS0 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ APAF1 O14727 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CASP8 Q14790 1/20 0.36
▸ GPR35 Q9HC97 1/20 0.36
▸ CLK1 P49759 1/20 0.35
▸ CLK2 P49760 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13219226 0.94 HDAC6 (0.43) HDAC6FFAR1EGLN2MAPTLMNA
SCHEMBL13219225 0.84 MAPT (0.41) HDAC6FFAR1MAPTLMNAKLKB1
SCHEMBL13219227 0.81 LMNA (0.42) LMNAPTGDR2PPARGPPARDPPARA
SCHEMBL3034325 0.80 PPARG (0.51) FFAR1MAPTLMNAMEN1POLB
SCHEMBL3025310 0.79 PPARG (0.62) PPARGPPARDPPARA
SCHEMBL13219232 0.78 ADAMTS4 (0.47) FFAR1KMT2APTGDR2PPARGPPARD
SCHEMBL13219211 0.77 TBXAS1 (0.42) EGLN2MAPTMEN1KMT2APTGDR2
SCHEMBL13219212 0.76 PPARG (0.43) FFAR1MAPTLMNAMEN1POLB
SCHEMBL13219234 0.76 FFAR1 (0.46) FFAR1MAPTMEN1POLBKMT2A
SCHEMBL13219219 0.76 PPARG (0.40) FFAR1MAPTMEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367828-B2 PPAR active compounds PLEXXIKON INC. (US) 2013-02-05 — — US disclosed
US-8367828-B2 PPAR active compounds PLEXXIKON INC. (US) 2013-02-05 — — US disclosed
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PLEXXIKON, INC. 2010-08-19 — — US disclosed
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PLEXXIKON, INC. 2010-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PPARG, PPARD, PPARA HDAC6 310/4885P2RY14 639/4885FFAR1 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback